Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Stock Price

TAKStock
$18.35+5.51%52W
Market Cap$58.60B
P/E48.02x
PEG Ratio0.41
Div yield4.41%
Beta0.22

TAK Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-7.70%
Price vs S&P 500 (4W)-1.85%
PEG Ratio0.41
VGM Score54.42
P/E Ratio (Annual)48.02x
Indicated Dividend Yield (Annual)4.41%

TAK Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.95
3.95
3.95
3.90

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
CCC$18.35
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Japan's largest pharmaceutical company with JPY 4.6 trillion in fiscal 2024 revenue. Takeda derives over 80% of sales from five core therapeutic areas: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies. Geographic revenue is well-diversified across the US (over 50%), Japan (20%), and Europe/Canada (20%).